[go: up one dir, main page]

GB0817622D0 - Antibody - Google Patents

Antibody

Info

Publication number
GB0817622D0
GB0817622D0 GB0817622A GB0817622A GB0817622D0 GB 0817622 D0 GB0817622 D0 GB 0817622D0 GB 0817622 A GB0817622 A GB 0817622A GB 0817622 A GB0817622 A GB 0817622A GB 0817622 D0 GB0817622 D0 GB 0817622D0
Authority
GB
United Kingdom
Prior art keywords
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0817622A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB SA
Original Assignee
UCB SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCB SA filed Critical UCB SA
Priority to GB0817622A priority Critical patent/GB0817622D0/en
Publication of GB0817622D0 publication Critical patent/GB0817622D0/en
Ceased legal-status Critical Current

Links

GB0817622A 2008-09-25 2008-09-25 Antibody Ceased GB0817622D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0817622A GB0817622D0 (en) 2008-09-25 2008-09-25 Antibody

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0817622A GB0817622D0 (en) 2008-09-25 2008-09-25 Antibody

Publications (1)

Publication Number Publication Date
GB0817622D0 true GB0817622D0 (en) 2008-11-05

Family

ID=40019584

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0817622A Ceased GB0817622D0 (en) 2008-09-25 2008-09-25 Antibody

Country Status (1)

Country Link
GB (1) GB0817622D0 (en)

Similar Documents

Publication Publication Date Title
IL276622A (en) Antibody formulation
EP2241578A4 (en) Anti-cldn6 antibody
ZA201102119B (en) Improved antibody libraies
GB0821100D0 (en) Antibodies
SI2146745T1 (en) penta-specific antibody
EP2138576A4 (en) Anti-claudin-4 antibody
GB0708002D0 (en) Antibodies
ZA201104545B (en) Anti-siglec-15 antibody
IL214996A0 (en) Anti-bcma antibodies
GB0920127D0 (en) Antibodies
GB0909906D0 (en) Antibodies
EP2427496A4 (en) Anti-vegf-d antibodies
ZA201006099B (en) Anti-tyrp1 antibodies
IL205073A0 (en) Anti-bst2 antibody
GB0718737D0 (en) Antibodies
GB0920324D0 (en) Antibodies
GB0905972D0 (en) Antibodies against IL-17BR
ZA201007976B (en) Anti-pirb antibodies
EP2499256A4 (en) Anti-c-mpl antibodies
GB0818356D0 (en) Antibodies
GB2473934B (en) Anti-VEEV antibody
GB0911770D0 (en) Antibody
EP2264071A4 (en) Antibody having an immune-enhancement function
GB0817621D0 (en) Antibody
GB0817622D0 (en) Antibody

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)